Further reading

AuthorEuropean Monitoring Centre for Drugs and Drug Addiction (EU body or agency)
TECHNICAL REPORT | Balancing access to opioid substitution treatment with preventing diversion of medications
WHO (2011), Ensuring balance in nati onal policies on controlled substa nces: guidance for availability and
accessibility of controlled medicines, WHO, Geneva.
Winstock, A. R., Lea, T. and Jackson, A. P. (2009a), Methods and motivations for buprenorphine
diversion from public opioid substitu tion treatment clinics, Journal of Addictiv e Diseases 28, pp.
Winstock, A. R., Lea, T. and Sheridan, J. (2009b), What is diversion of s upervised buprenorphine and
how common is it?, Journal of Addictiv e Diseases 28, pp. 269-278.
Worley, J. and Thomas, S. P. (2014), Women who d octor shop for prescription drugs, Western Journal
of Nursing Research 36, pp. 456-474.
Wright, C. (1992), Medical Officer Briefing Pac kage: The Houston Methadone Ou tbreak, Food and Drug
Administration, Rockville.
Wright, N., DAgnone, O., Krajci, P., Littlewood, R., Alho, H., Reimer, J., Roncero, C., Soma ini, L. and
Maremmani, I. (2016), Addressing mis use and diversion of opioid substitut ion medication:
guidance based on systematic evidence r eview and real-world experience, Jo urnal of Public
Health 38(3), pp. e368-e374.
Yokell, M., Zaller, N., Green, T. and R ich, J. (2011), Buprenorphine and bu prenorphine/naloxone
diversion, misuse, and Illicit use: an inter national review, Current Drug Abus e Reviews 4(1), pp.
Further reading
Darke, S., Topp, L. and Ross, J. (2002) , The injection of methadone and benz odiazepines among
Sydney injecting drug users 1996-2000 : 5-year monitoring of trends from the il licit drug reporting
system, Drug and Alcohol Review 21(1), pp. 27-32.
Kelleher, C. (2018), Characteristics of methadone-related overdose deaths an d comparisons between
those dying on and off opioid agonist treatment, Drugnet Ireland 64.
Launonen, E., Alho, H., Kotovirta, E., Wallace, I. and Simojoki, K. (2015), Diversion of opioid
maintenance treatment medications and predictors for diversion among Fi nnish maintenance
treatment patients, International Jour nal of Drug Policy 26(9), pp. 875-882.
Winstock, A., Lea, T. and Sheridan, J. (2008), Prevalence of diversion and injection of methadone and
buprenorphine among clients receivin g opioid treatment at community phar macies in New South
Wales, Australia, International Journa l of Drug Policy 19(6), pp. 450-458.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT